Macrocyclic trichothecenes (MTs), which have potent cytotoxicity, have been isolated from many different fungal species. These compounds were evaluated clinically by the US National Cancer Institute in the 1970s and 1980s. However, they have yet to be advanced into viable drugs because of severe side effects. Our team is investigating a diverse library of filamentous fungi for new anticancer leads. To avoid reisolating MTs through bioactivity-directed fractionation studies, a protocol for their facile dereplication was developed. The method uses readily available photodiode array detectors to identify one of two types of characteristic UV spectra for these compounds. In addition, diagnostic signals can be observed in the (1)H-NMR spectra, particularly for the epoxide and conjugated diene moieties, even at the level of a crude extract. Using these techniques in a complementary manner, MTs can be dereplicated rapidly.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946446PMC
http://dx.doi.org/10.1038/ja.2010.77DOI Listing

Publication Analysis

Top Keywords

macrocyclic trichothecenes
8
filamentous fungi
8
dereplication macrocyclic
4
trichothecenes extracts
4
extracts filamentous
4
fungi nmr
4
nmr profiles
4
profiles macrocyclic
4
trichothecenes mts
4
mts potent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!